Rispide 0,5, 1, 2, 3, 4 & 6 0,5, 1, 2, 3, 4 & 6mg FC tablets.
PDF Leaflet Revision Date: 01 April 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of schizophrenia and behavioral disturbances in dementia.
Dosage (summary)
Adults: Start at 2 mg/day, may increase to 4-8 mg/day. Elderly: Start at 0.5 mg twice daily.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; may cause neonatal withdrawal symptoms.
Key Drug Interactions
- CYP2D6 inhibitors
- CYP3A4 inhibitors
- Furosemide
Contraindications
- Hypersensitivity to risperidone
- Parkinson's disease
- Dementia with Lewy bodies
Common side effects
- Weight gain
- Hyperprolactinaemia
- Dizziness
- Sedation
Counselling Points
- Monitor for weight gain
- Avoid alcohol
- Caution with driving or machinery
Serious warnings
- Tardive dyskinesia
- Neuroleptic malignant syndrome
- Cerebrovascular adverse events
Important Disclaimer
The Rispide 0,5, 1, 2, 3, 4 & 6 0,5, 1, 2, 3, 4 & 6mg FC tablets. professional information leaflet below is the property of Abex Pharmaceutica and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
